University of Dundee granted $15.7 million from Wellcome Trust
April 2012

DUNDEE, U.KóThe Wellcome Trust has granted the University of Dundee more than $15.7 million to support research into highly neglected parasitic diseases. The deal includes $13.5 million of support for a partnership with GlaxoSmithKline PLC (GSK) for new drug treatments, in which the Drug Discovery unit at Dundee will collaborate with GSK's Kinetoplastids Discovery Performance unit at the company's Tres Cantos Medicines Development Campus in Spain. The partners will seek to develop treatments for leishmaniasis, Chagas disease and African sleeping sickness, with the goal of having at least one treatment for one of the diseases in the next five years. Work has been underway at the university on a treatment for African sleeping sickness for the past five years, and the university says there have been encouraging developments in terms of potential treatments for leishmaniasis.